StockData
Merck & Co., Inc. logo

Merck & Co., Inc. (MRK) stock

MRKNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 9/30240% above fair value
$137.78−5.59 (-3.90%)

Close on Nov 18, 2026Market cap $339.93BP/E 110.2Yield 2.38%

Merck operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

No operating income figures for Merck

Merck has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More Merck figures

See a number that looks wrong?